Vericel Corp Ord (VCEL)
US$ 39.7299-3.31%
Price Chart
Key Statistics
Market Cap
$ 2.14B
P/E Ratio
849.60
Revenue (TTM)
$ 238.54M
Volume
444.53K
52W High
$ 63.00
52W Low
$ 37.39
Dividend Yield
0.00%
Beta
1.32
Technicals
50-Day MA
42.9514
200-Day MA
49.1464
52 Week High
63
52 Week Low
37.39
About VCEL
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports .
Employees
357
Headquarters
Cambridge, MA
CEO
Mr. Dominick C. Colangelo Esq.
Latest News
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates - MSN
2 days ago • Google News
Vericel Earnings: Sports Medicine Leader to Reveal Q1 2025 Performance on May 8 - Stock Titan
4 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg